Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up study of intensification therapy in type 2 diabetes
ChiCTR-TRC-10001264Phase 4Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Aug 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin and exenatide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Tangdu Hospital. Primary endpoints: Plasma insulin and C-peptide. Started Aug 2010; status: recruiting.
02
Drugs
human insulinexenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-10001264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001264.